Schedule 13D ownership disclosure
SORRENTO THERAPEUTICS IN
Security class unavailable · CUSIP: 83587F202
Event date: 2016-06-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,676,193
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-16-001076
- Form type
- SC 13D
- Filer
- Sorrento Therapeutics, Inc.
- CIK
- CIK 850261
- Filed
- Jun 02, 2016
- Reporting period
- Jun 01, 2016
- Description
- Schedule 13D beneficial ownership